Treatment of Functional Dyspepsia in Outpatients after COVID-19 Infection
Aim: to compare the efficacy of different therapeutic regimens for managing functional dyspepsia in outpatients after COVID-19 infection.Materials and methods. 42 post-COVID-19 outpatients (age: 26–47 years) diagnosed with functional dyspepsia (FD) according to the Rome IV Criteria were enrolled in...
Saved in:
Main Authors: | M. S. Turchina, Yu. M. Morozov, T. I. Obolenskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2023-05-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/780 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern Possibilities of Using Acotiamide in the Treatment of Functional Dyspepsia
by: A. A. Sheptulin, et al.
Published: (2024-03-01) -
Modern approaches to functional dyspepsia treatment
by: A. A. Sheptulin
Published: (2014-12-01) -
Role of depression in development of functional dyspepsia symptoms
by: D. B. Kolesnikov, et al.
Published: (2011-06-01) -
Diet in the Management of Functional Dyspepsia: Controversial and Unresolved Issues
by: A. A. Sheptulin, et al.
Published: (2023-09-01) -
Efficacy of Trimebutine Maleate (Trimedat®) in the Treatment of Patients with Functional Dyspepsia: Results of the “TREND” Observational Study
by: S. S. Kardasheva, et al.
Published: (2018-11-01)